Targeted genotyping of COVID-19 patients reveals a signature of complement C3 and factor B coding SNPs associated with severe infection.

Journal Information

Full Title: Immunobiology

Abbreviation: Immunobiology

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Allergy and Immunology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
4/6
66.7% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Evidence found in paper:

"appendix a supplementary data the following are the supplementary data to this article: supplementary data 1 data availability data availability: the authors declare that data supporting the findings of this study are available within the paper and its supplementary information files."

Code Sharing
Evidence found in paper:

"Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper."

Evidence found in paper:

"Sources of funding The genetic analysis was supported by an independent investigator driven grant (Pfizer Pharmaceuticals) as well as by COVID-19 research funding by the Prefecture of Central Macedonia in Thessaloniki, Greece."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025